Eczema that refuses to clear despite doing everything a dermatologist recommends is more common than most patients realize, and dermatology’s governing body just weighed in on why. The American Academy of Dermatology (AAD) has released its first-ever guidelines specifically for adults whose atopic dermatitis (AD) isn’t responding to treatment.
The guidance opens with an idea that runs against instinct: the fix might not be a stronger drug. It might be a different diagnosis. The misdiagnosis problem with eczema is something dermatologists have been raising for a while, and this is the first time the AAD has given doctors a formal playbook for it.
Ahead, what the new guidelines say about misdiagnosis, the conditions that can masquerade as eczema and when it’s time to ask your dermatologist for a second look.
Why Adult Eczema Is So Easy to Get Wrong
The guidelines, published August 31 in the Journal of the American Academy of Dermatology, zero in on a detail that trips up a lot of care: about 1 in 4 adult AD cases actually start in adulthood, a pattern that’s historically harder to diagnose than the childhood version most people associate with eczema. Roughly 2 percent of adults worldwide have AD, and until now there’s been no dedicated guidance on what to do when a presumed case just won’t respond. Rochester, MN dermatologist Dawn Davis, MD, senior author of the guidelines, told Medscape that persistent, treatment-resistant symptoms are a signal to reconsider the diagnosis altogether rather than assume the case is simply harder to treat.
The Conditions That Can Hide Behind an Eczema Diagnosis
The guidelines list out a handful of look-alikes and co-travelers that can explain a stalled treatment plan: allergic or irritant contact dermatitis, food allergies, asthma, allergic rhinitis, psoriasis, hives and in rare cases, a form of skin lymphoma. Davis described watching this play out in her own patients, whose eczema flares don’t always trace back to eczema itself. It’s the same overlap dermatologists have pointed to elsewhere, where a reaction to something in a skin care ingredient turns out to be driving symptoms that get chalked up to eczema.
What the Guidelines Actually Tell Dermatologists to Do
Instead of a one-size-fits-all test, the guidelines give doctors a decision tree based on what a case looks like. Patch testing is highlighted for adult-onset eczema, rashes in unusual places like the hands or eyelids, or dermatitis that isn’t budging under standard treatment. Biopsies come into play when something about the case looks more like a different condition entirely. Skin scraping and cultures help rule out infections or infestations that can mimic eczema. And when none of that clears things up, the guidelines say the next step is a referral to a specialist, not another treatment escalation.
The Takeaway for Anyone Whose Eczema Isn’t Improving
Chicago dermatologist Peter Lio, MD, a clinical assistant professor at Northwestern University Feinberg School of Medicine who wasn’t involved in writing the guidelines, called the message underneath all of this “deceptively simple”: don’t assume a stalled treatment means the disease is just stubborn. For patients, that reframe is good news. If your eczema treatment has stopped working the way it should, this is a reason to bring it up with your dermatologist as a diagnosis question, not just a dosage one. It’s a similar shift in thinking to the one behind recent dosing updates for eczema biologics, where the goal is matching treatment to the individual patient rather than a single fixed protocol.
